Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Antitumor activity of novel PI3K inhibitor reported by Zentaris

May 4, 2007

Treatment begins in pivotal study of picoplatin for SCLC

May 3, 2007

Phase II trials planned for VQD-002

May 3, 2007

Novel JAK2/FLT3 inhibitor shows promise for the treatment of myeloproliferative disorders

May 3, 2007

Preclinical antitumor profile of Serono's Aurora kinase inhibitor AS-703569

May 3, 2007

Positive results from preclinical pharmacokinetic testing of ANX-514

May 3, 2007

Acceptable safety profile emerges from early clinical trial with masitinib

May 2, 2007

GSK-461364, a potent, selective small-molecule PLK1 inhibitor selected for further development

May 2, 2007

CDK inhibitor SNS-032 induces apoptosis in multiple myeloma cells

May 2, 2007

CDC25 phosphatase inhibition with IRC-083864 suppresses tumor growth in vitro and in vivo

May 2, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...